Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. - Wikidata - awgldk - TriplyDB

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

http://www.wikidata.org/entity/Q44897370

about

Motion management in gastrointestinal cancers Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen).Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer.Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer Chemoradiation in pancreatic adenocarcinoma: a literature review.Adjuvant and neoadjuvant treatment in pancreatic cancer Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer The role of radiotherapy in management of pancreatic cancer Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer.Capecitabine in carcinoma of the pancreas.Analysis of local control in patients receiving IMRT for resected pancreatic cancers Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.Intensity modulated radiation therapy: a review of current practice and future directions.Increased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinoma.Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer.Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer.Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer.A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer.Is there a role for advanced radiation therapy technologies in the treatment of pancreatic adenocarcinoma?Intensity-modulated radiation therapy for gastrointestinal tumors.Preliminary experience of helical tomotherapy for locally advanced pancreatic cancer Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity.Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution.Role of intensity-modulated radiation therapy in gastrointestinal cancer.Consensus on the treatment of pancreatic cancer in Spain.Stereotactic body radiation therapy planning with duodenal sparing using volumetric-modulated arc therapy vs intensity-modulated radiation therapy in locally advanced pancreatic cancer: a dosimetric analysis.The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma.Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning.Role of radiation therapy in the management of pancreatic cancer.Treatment options for advanced pancreatic cancer: a review.Dose-painted intensity modulated radiation therapy improves local control for locally advanced pancreas cancer.Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies.Concurrent capecitabine and upper abdominal radiation therapy is well tolerated A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas.Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection.Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer. Outcome analysis and comparison with a 3D-treated patient cohort.Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.Intensity modulated radiotherapy: advantages, limitations and future developments.

P2860

Q27024637-6F240C96-628F-49A5-8C2F-908C4083AFA3 Q33393039-1D55F009-CF32-4E80-BA57-5F4B6BCF3F36 Q33810863-55A21028-116C-40D2-8D81-07387A8612E1 Q33993645-4225747B-578C-4D8A-8B07-9B89AA93E90B Q34449812-FD93BCF0-4A61-411B-A6B7-04E8420A8DCD Q35147520-C80F42EF-6EF5-4D51-B976-C7BC92946F04 Q35583949-261FAC5E-8FE6-443B-91DA-183C1CFD2587 Q35886631-C7991DBA-EB3C-4665-BAA5-52D9DAF0452D Q35931385-4AB39895-2794-43AB-8B1F-92BEE5E58A28 Q36097189-96E81C52-39EB-4199-8D16-5EE073785289 Q36503249-F35D460C-E2AE-4DFF-AE5D-4BD8FBFCD522 Q36548730-DE5FFE54-1309-4490-92A3-B7D6ABC5D008 Q36567665-342B4202-3517-4966-AAC2-4A6CC0D42871 Q36572889-1A00F2C8-6B8D-4238-993D-808CD1481373 Q36596630-2D535CC0-1716-47CD-8F41-A6A482F481B8 Q36626546-E7EA8CCC-12FC-4B3D-9274-7AC23D62F7C6 Q36627147-296DE701-AF0B-4DE6-812D-A0BC60C873BA Q36661834-6604895F-10EE-4280-B68A-FC3BB99DED42 Q36985745-1EEB65B6-B522-4B75-A61F-295ACC7A6B54 Q37080999-8B8FAA19-3222-4F53-9976-98E6432117CD Q37137013-11258B75-AA5E-4E88-92D0-AE77301CCB55 Q37258940-F256E574-940F-4FE0-AC6C-AE36F47D8486 Q37353875-2316AF0A-B513-45F3-971C-BDD305544295 Q37355811-28C517ED-2DD6-41D5-AB9A-3D0B247F44E9 Q37460385-703000D8-5816-401B-8436-D6F2B937ED69 Q37483982-506CBBB7-1447-4FF0-B5D9-4BB97CE63226 Q37487167-05ADC438-8046-4BD3-A073-4C91ACD4E54B Q37715120-C70EDFAA-C9F3-481C-AF1F-934CC8B854FB Q37723257-DFAB05AB-89EF-4D21-84C1-F57C45343BB4 Q37779912-9D12C234-D5C9-4CB3-B664-00C85B13FFE4 Q38005349-6279C70F-2836-4508-96B4-9C211901FE47 Q38062020-BB71581D-4AE1-41A7-BA22-C35A889204A2 Q38429492-97FB2F67-B22C-4B23-A911-313A6D31D6DB Q39025952-CF127C5C-4591-4046-AABE-87410F8196B4 Q39063211-6D7FB93A-278C-432C-AE32-7C68C7B556A3 Q39149609-872FFF13-EB86-4AC0-BBB4-E49B136794D5 Q39234276-0359EC4A-3F43-4F38-A1E2-20169269F9BE Q39376002-54E538AC-539E-44A5-8D09-52F8BFFEBD1A Q39740700-C50C319F-44B0-4073-9289-F05CFCD28CC9 Q40361409-AD5B9376-1768-41E6-A0AC-DF956AB0AC3D

P2860

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.

http://www.wikidata.org/entity/Q44897370

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Intensity-modulated radiothera ...... itabine for pancreatic cancer.

@en

type

label

Intensity-modulated radiothera ...... itabine for pancreatic cancer.

@en

prefLabel

Intensity-modulated radiothera ...... itabine for pancreatic cancer.

@en

P1433

Q44897370-B61726BD-4589-464A-9730-F170ADFEAB5F

P1476

Q44897370-264F1AF6-F5B9-4F65-9534-3CCD4EE9E9CE

P2093

Q44897370-256C761B-01D9-4566-A0A6-8CBFCF10EB97

Q44897370-3C10E5CA-4DAC-4C17-A3C5-9D44C12E6903

Q44897370-4B549972-9E1E-4EF0-BA97-4AD4F253FF42

Q44897370-58C7B938-B65B-42A9-A2E1-B63AC0EA8370

Q44897370-6DCB8E6D-AF76-42F1-B25B-7FB2C4E39CA4

Q44897370-6E06DC9B-3A7B-4DFC-BE2E-4A28678A573A

Q44897370-A240B56C-E783-44F0-8D82-F34F264D4FDB

Q44897370-C32CF81E-9863-43FD-A3CA-CC6A21BF8C9B

Q44897370-F3569402-4FAB-4BCD-8476-611D96E949A4

P304

Q44897370-D06B3BDA-8D8A-415A-9951-A36C14006FBF

P31

Q44897370-207163CB-5F66-4680-8DB6-1B066E6D51A7

P356

Q44897370-C5020FB5-6151-49BF-B091-FE3A6F04CB5A

P407

Q44897370-0C6A691F-05EA-4A71-87FD-766006504FAF

P433

Q44897370-7A16D0B0-E3F8-4644-8F38-B126C1B3B8D4

P478

Q44897370-10BF6BA3-16F3-40B4-A335-A88CC99CC871

P577

Q44897370-2B7A9537-5947-4E9B-8B22-33050E3C5124

P698

Q44897370-B0F095E7-B93F-4F98-996C-390E89C0D9B6

P921

Q44897370-3D53A1DB-8C25-48AF-BA79-66A2E6F79405

P356

J.IJROBP.2003.11.019

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Intensity-modulated radiothera ...... itabine for pancreatic cancer.

@en

P2093

Anthony F Shields

http://www.w3.org/2001/XMLSchema#string

Basil F El-Rayes

http://www.w3.org/2001/XMLSchema#string

Edgar Ben-Josef

http://www.w3.org/2001/XMLSchema#string

Jay Burmeister

http://www.w3.org/2001/XMLSchema#string

Patrick McDermott

http://www.w3.org/2001/XMLSchema#string

Philip A Philip

http://www.w3.org/2001/XMLSchema#string

Todd Bossenberger

http://www.w3.org/2001/XMLSchema#string

Ulka Vaishampayan

http://www.w3.org/2001/XMLSchema#string

Vainutis Vaitkevicius

http://www.w3.org/2001/XMLSchema#string

P304

454-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2003.11.019

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15145162

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy